8-K filed Apr 23, 2026 at 15:49 ET
Utah Medical Products (UTMD) reported Q1 2026 earnings with revenue of $8.72M, down 10.2% YoY, and EPS of $0.818, down 11.0%. The decline was driven by the expected loss of $857K in sales from two former customers (PendoTECH and a China distributor), partially offset by a 47.4% increase in domestic Filshie device sales. Gross margin improved to 60.6% due to favorable product mix and a one-time inventory adjustment.